The Healthcare Packaging Market to 2028

Product code:PACK2028

Availability: In stock

€1,999.00

Qty: Buy Now - OR -

Released 24/11/2017

98 pages

Over 50 Tables and Figures

 

GMR Data forecast The Healthcare Packaging Market to reach $117.2bn by 2028


The Healthcare Packaging Market to 2028, the latest report from business intelligence provider GMR Data, offers comprehensive analysis of the global healthcare packaging market. GMR Data assesses that this market will generate revenues of $117.2bn in 2018.

Read on to discover the most lucrative areas in the industry and the future market prospects.

In this brand new 98-page report you will receive over 50 tables & figures – all unavailable elsewhere. By ordering and reading our brand new report today you stay better informed and ready to act.

 

Healthcare Packaging Market Drivers include


  • Non-Adherence driven development – compliance packaging / Track & Trace
  • Growing OTC sector
  • Increasing purchasing power parity of consumers
  • Increasing global NCD population


Restraints include


  • Stringent regulations
  • Infrastructural Challenges – distribution networks
  • Generic Medicine growth


GMR Data’s The Healthcare Packaging Market to 2028, also benefits from 3 exclusive interviews with representatives from;

  • Gerresheimer
  • DuPont (Tyvek)

 

These leading, in the field, experts offer exclusive insight into the Healthcare Packaging sector; how they see the market currently, which geographical areas will witness growth and which sub sectors face perhaps face an uncertain growth trajectory.

 

 Executive Summary

The global pharmaceutical and medical devices market are a combined $1.2 trillion market; the prime requisite in transport and delivery of drugs or medical devices is - packaging. Packaging, thus comprises 6% to 10% of the total sales of the healthcare (pharmaceutical and medical devices) market. Both of these markets are forecast to grow in the region of 4% CAGR across 2018-2028. The Healthcare Packaging market value reached $110 billion in 2017 and is estimated to grow in the region of 8% CAGR from 2018 - 2028, which indicates the economic significance of the Healthcare Packaging market. 

In the modern age tablets/capsules/liquids are packaged in small glass or plastic bottles, blister packs or in large volume glass bottles. With the commercialisation of Biologics/Biosimilars; with the change in disease pattern globally from infectious to Non-Communicable Diseases (NCDs), and the rise in selfadministered drugs, especially in the home-healthcare management of NCDs such as Diabetes, Autoimmune Diseases, Deep Vein Thrombosis, Biologics and Vaccinations - packaging such as prefilled sy ringes, inhalers, ampoules, and vials are witnessing an increased demand. Trends such as telemedicine and ‘Point-Of-Care’ diagnostics, calls for the suitable transport and distribution of such diagnostic aids - the ‘Point-Of-Care’ diagnostics (along with other medical devices such as Implants) are appropriately packaged and transported in thermoformed containers, hence the demand for clamshell packs and thermoformed trays.

 

To order this report today get in touch via info@gmrdata.com or go to gmrdata.com

 

 

Chapter 1 - Executive Summary
1.1 Executive Summary
1.2 Report Description
1.3 Market Segmentation
1.4 Research Methodology
 
Chapter 2 - Introduction to the Healthcare Packaging Market
2.1 Definition of Healthcare Packaging
2.2 Regulatory Overview of Healthcare Packaging
2.3.1. Regulations and Testing for Packaging of Non-Sterile Medical Devices
2.3.2. Regulations and Testing for Packaging of Sterile Medical Devices
2.3.3. Packaging Performance Testing / Distribution Simulation - ISTA 1,2,3
2.3.4. Packaging Performance Testing / Distribution Simulation - ASTM D4169
2.3.5. Stability Testing / Shelf Life Study - Accelerated Aging
2.3.6. Stability Testing / Shelf Life Study - Real Time Aging
2.3.7. Packaging System Integrity Testing
2.3.8. ISO 11607 compliant Standardized Test Methods, US market
2.3.9. Testing and Validation Process for Packaging of Medical Devices
2.3.10. Regulations and Testing for Packaging of Pharmaceuticals
2.3.11. Regulations on Labelling in Healthcare Packaging
2.3.12. Proposed Regulations and Testing in Healthcare Packaging
2.3.13. Drawbacks in Current Regulations in Healthcare Packaging
 
Chapter 3 - Healthcare Packaging Market, by Type, 2018-2028
3.1 Pharmaceutical Packaging Market, 2018–2028
3.1.1. Small Volume Bottles Packaging Market, 2018–2028
3.1.2. Large Volume Parenterals Packaging Market, 2018–2028
3.1.3. Blisters Packaging Market, 2018–2028
3.2 Sterile (Diagnostic/Infectious) Packaging Market, 2018–2028
3.2.1. Pre-Filled Syringes and Inhalers Packaging Market, 2018–2028
3.2.2. Ampoules and Vials Packaging Market, 2018–2028
3.2.3. Thermoformed Containers Packaging Market, 2018–2028
3.3 Medical Devices Packaging Market, 2018–2028
3.3.1. Clamshell Packs Packaging Market, 2018–2028
3.3.2. Thermoformed Trays Packaging Market, 2018–2028
3.3.3. Pharmaceutical Pouches Packaging Market, 2018–2028
3.4 Emerging/Other Healthcare Packaging Market, 2018–2028
3.4.1. Anti-Counterfeit Packaging Market, 2018–2028
3.4.2. Braille-Compliant Packaging Market, 2018–2028
3.4.3. Child-Resistant Packaging Market, 2018–2028
 
Chapter 4 - Healthcare Packaging Market, by Country, 2018-2028
4.1 US Healthcare Packaging Market and Forecast, 2018 - 2028
4.2 Canada Healthcare Packaging Market and Forecast, 2018 - 2028
4.3 UK Healthcare Packaging Market and Forecast, 2018 - 2028
4.4 France Healthcare Packaging Market and Forecast, 2018 - 2028
4.5 Germany Healthcare Packaging Market and Forecast, 2018 - 2028
4.6 Spain Healthcare Packaging Market and Forecast, 2018 - 2028
4.7 Italy Healthcare Packaging Market and Forecast, 2018 - 2028
4.8 China Healthcare Packaging Market and Forecast, 2018 - 2028
4.9 India Healthcare Packaging Market and Forecast, 2018 - 2028
 
Chapter 5 - Key Companies in the Healthcare Packaging Market
5.1 Overview
5.2 Bemis Healthcare Packaging
5.2.1. Background
5.2.2. Business Structure
5.2.3. Products / Services
5.2.4. Growth Strategy
5.2.5. Financial Information
5.3 Becton Dickinson & Co.
5.3.1. Background
5.3.2. Business Structure
5.3.3. Products / Services
5.3.4. Growth Strategy
5.3.5. Financial Information
5.4 DuPont (Tyvek)
5.4.1. Background
5.4.2. Business Structure
5.4.3. Products / Services
5.4.4. Growth Strategy
5.4.5. Financial Information
5.5 Gerresheimer
5.5.1. Background
5.5.2. Business Structure
5.5.3. Products / Services
5.5.4. Growth Strategy
5.5.5. Financial Information
5.6 Sonoco Thermosafe
5.6.1. Background
5.6.2. Business Structure
5.6.3. Products / Services
5.6.4. Growth Strategy
5.6.5. Financial Information
5.7 Sproxil
5.7.1. Background
5.7.2. Business Structure
5.7.3. Products / Services
5.7.4. Growth Strategy
5.7.5. Financial Information
5.8 Unither Pharmaceuticals
5.8.1. Background
5.8.2. Business Structure
5.8.3. Products / Services
5.8.4. Growth Strategy
5.8.5. Financial Information
5.9 West Pharmaceutical Services, Inc.
5.9.1. Background
5.9.2. Business Structure
5.9.3. Products / Services
5.9.4. Growth Strategy
5.9.5. Financial Information
 
Chapter 6 - Drivers & Restraints of the Healthcare Packaging Market 2018-2028
6.1 Economic Significance of Standardized Healthcare Packaging
6.2 Growth Drivers
6.2.1. Increasing consumption of Biologics
6.2.2. Approval of Opioids for medicinal purposes
6.2.3. Non-adherence driven development and uptake of novel packaging
6.2.4. Focus on development of ‘patient-centric’ healthcare packaging
6.3 Restraints and Challenges
6.3.1. Unfavorable economics
6.3.2. Challenging regulations for newer healthcare products
6.3.3. Challenges in development of packaging material for newer healthcare products
6.4 Trends and Future Outlook
6.4.1. Real-time Customer and Channel Intelligence via’ packaging
6.4.2. Sustainability in Healthcare Packaging
6.4.3. Economizing Healthcare Packaging operations
6.4.4. Current trends reflect Future Outlook - Latent demand in Healthcare Packaging material design
 
Chapter 7 - Expert Opinion
7.1 Gerresheimer
7.2 Gerresheimer
7.3 DuPont (Tyvek)